Showing results (121-130 of 391) with videos related to

Sort By:
Pageof 40
The Journal of Infectious Diseases|March 4, 2025
Dolutegravir and Risk of Neuropsychiatric Adverse Events: a Pharmacogenetic StudyJulien De Greef, Jean Cyr Yombi, Anne Vincent, et al.
EMBO Molecular Medicine|March 24, 2016
Chronic oxidative stress promotes H2AX protein degradation and enhances chemosensitivity in breast cancer patientsTina Gruosso, Virginie Mieulet, Melissa Cardon, et al.
Bulletin Du Cancer|June 10, 2017
[Internal quality control on HER2 status determination in breast cancers: Experience of a cancer center]Carine Ngo, Marick Laé, Julia Ratour, et al.
The Journal of Pathology|November 27, 2014
SF3B1 mutations constitute a novel therapeutic target in breast cancerSarah L Maguire, Andri Leonidou, Patty Wai, et al.
Cancers|May 14, 2022
Oral Etoposide and Trastuzumab Use for HER2-Positive Metastatic Breast Cancer: A Retrospective Study from the Institut Curie HospitalsClelia Chalumeau, Matthieu Carton, Alexandre Eeckhoutte, et al.
Analytical Chemistry|May 4, 2026
Circulating Tumor DNA Monitoring in Patients with Uveal Melanoma Using Mutation-Agnostic Multiplex Drop-Off ddPCR AssaysAurore Rampanou, Manuel Rodrigues, François-Clément Bidard, et al.
Oncology|October 3, 2018
A New Transcutaneous Method for Breast Cancer Detection with DogsAurélie Thuleau, Caroline Gilbert, Pierre Bauër, et al.
Acta Ophthalmologica|March 25, 2016
Choroidal melanoma and pregnancyStéphanie Lemaître, Christine Lévy-Gabriel, Laurence Desjardins, et al.
Bulletin Du Cancer|December 15, 2015
[Perception of pT1a,b pN0 breast tumor prognosis by the French oncology community: Results of the EURISTIC national survey]Marc Spielmann, Florence Dalenc, Yoann Pointreau, et al.
EMBO Molecular Medicine|January 10, 2013
The Huntington disease protein accelerates breast tumour development and metastasis through ErbB2/HER2 signallingCristovão Moreira Sousa, John Russel McGuire, Morgane Sonia Thion, et al.
Pageof 40